Latest AI and machine learning research in prescriptions for healthcare professionals.
To solve the problem of inaccurate prediction caused by the lack of representativeness of samples due to the small sample size of the collected clinical data when using machine learning methods to predict drug concentration in plasma and describe the hysteresis phenomenon of drug effect lagging behind plasma drug concentration, this paper proposes a pharmacokinetic-pharmacodynamic (PK-PD) model ba...
How do we switch between "playing along" and treating robots as technical agents? We propose interaction breakdowns to help solve this "social artifact puzzle": Breaks cause changes from fluid interaction to explicit reasoning and interaction with the raw artifact. These changes are closely linked to understanding the technical architecture and could be used to design better human-robot interactio...
The potential for complex systems to exhibit tipping points in which an equilibrium state undergoes a sudden and often irreversible shift is well esta...
Glioma is heterogeneous disease that requires classification into subtypes with similar clinical phenotypes, prognosis or treatment responses. Metabol...
The identification of drug-target relations (DTRs) is substantial in drug development. A large number of methods treat DTRs as drug-target interaction...
Drug-drug interactions are one of the main concerns in drug discovery. Accurate prediction of drug-drug interactions plays a key role in increasing th...
Many high-performance DTA deep learning models have been proposed, but they are mostly black-box and thus lack human interpretability. Explainable AI ...
Previous models have shown that learning drug features from their graph representation is more efficient than learning from their strings or numeric r...
Identifying molecular targets of a drug is an essential process for drug discovery and development. The recent in-silico approaches are usually based ...
The discovery and development of new drugs are extremely long and costly processes. Recent progress in artificial intelligence has made a positive imp...
Drug-target binding affinity prediction plays a key role in the early stage of drug discovery. Numerous experimental and data-driven approaches have b...
BACKGROUND: Drug discovery processes, such as new drug development, drug synergy, and drug repurposing, consume significant yearly resources. Computer...
Chemogenomics, also known as proteochemometrics, covers various computational methods for predicting interactions between related drugs and targets on...
This study aimed to evaluate the accuracy of automated deep learning (DL) algorithm for identifying and classifying various types of dental implant sy...
OBJECTIVES: The aim of this study is to investigate the effect of artificial intelligence (AI) and/or algorithms on drug management in primary care se...
Sensorimotor control (SMC) is a complex function that involves sensory, cognitive, and motor systems working together to plan, update and execute volu...
BACKGROUND: Drug‒drug interactions (DDIs) are reactions between two or more drugs, i.e., possible situations that occur when two or more drugs are use...
One of the main obstacles to the successful treatment of cancer is the phenomenon of drug resistance. A common strategy to overcome resistance is the ...
When performing a joint action task, we automatically represent the action and/or task constraints of the co-actor with whom we are interacting. Curre...
Drug synergy is a crucial component in drug reuse since it solves the problem of sluggish drug development and the absence of corresponding drugs for ...